Stock Report: Conceptus Inc. (CPTS) Report Updated: May 20, 2013 | Print This Page
Report Features:
Stock Analysis
Rating: Monthly View
| A | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| F | ||||||||||||
Rating: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |

Company Profile
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. It primarily provides Essure, a permanent birth control system that delivers an insert into a woman’s fallopian tubes. The company sells its products through direct sales personnel and distributors primarily to physicians and hospitals. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California.
Recent News: Conceptus Inc.
| 2012-10-23 16:05:12 | Conceptus(R) Reports Third Quarter Financial Results |
| 2012-10-23 00:00:00 | Report of unscheduled material events or corporate changes - Form 8-K |
| 2012-10-02 17:00:12 | Conceptus(R) to Hold Third Quarter Financial Results Conference Call on October 23, 2012 |
| 2012-08-21 00:00:00 | Securities offered to employees under employee benefit plans - Form S-8 |
| 2012-08-15 16:36:13 | Conceptus(R) to Participate in Three Investor Conferences |
My Portfolios (View All)
Save your portfolio—or a few for that matter—and check up on your stocks 24/7! Log in here.
Louis Navellier's Portfolios
- Blue Chip GrowthTop blue chips
- Emerging GrowthTop small-caps
- Ultimate GrowthFastest-moving
- Platinum GrowthElite Model Portfolio



